105 related articles for article (PubMed ID: 11044472)
1. Gene therapy for XSCID: the first success of gene therapy.
Kohn DB
Pediatr Res; 2000 Nov; 48(5):578. PubMed ID: 11044472
[No Abstract] [Full Text] [Related]
2. Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency.
Felsburg PJ; Somberg RL; Hartnett BJ; Suter SF; Henthorn PS; Moore PF; Weinberg KI; Ochs HD
Blood; 1997 Oct; 90(8):3214-21. PubMed ID: 9376605
[TBL] [Abstract][Full Text] [Related]
3. In vivo competitive studies between normal and common gamma chain-defective bone marrow cells: implications for gene therapy.
Otsu M; Sugamura K; Candotti F
Hum Gene Ther; 2000 Sep; 11(14):2051-6. PubMed ID: 11020803
[TBL] [Abstract][Full Text] [Related]
4. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.
Hacein-Bey-Abina S; Le Deist F; Carlier F; Bouneaud C; Hue C; De Villartay JP; Thrasher AJ; Wulffraat N; Sorensen R; Dupuis-Girod S; Fischer A; Davies EG; Kuis W; Leiva L; Cavazzana-Calvo M
N Engl J Med; 2002 Apr; 346(16):1185-93. PubMed ID: 11961146
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy of severe combined immunodeficiencies.
Cavazzana-Calvo M; Hacein-Bey S; Yates F; de Villartay JP; Le Deist F; Fischer A
J Gene Med; 2001; 3(3):201-6. PubMed ID: 11437325
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy. Hidden X factor.
Shamash J
Nurs Times; 2002 Apr 16-22; 98(16):10. PubMed ID: 11997983
[No Abstract] [Full Text] [Related]
7. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
8. [It is no more about cancer, but it is already about gene therapy].
Jeanteur P
Bull Cancer; 2000 Jun; 87(6):445-6. PubMed ID: 10928794
[No Abstract] [Full Text] [Related]
9. Bone marrow transplantation for canine X-linked severe combined immunodeficiency.
Hartnett BJ; Henthorn PS; Moore PF; Weinberg KI; Ochs HD; Felsburg PJ
Vet Immunol Immunopathol; 1999 Aug; 69(2-4):137-44. PubMed ID: 10507301
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy of severe combined immunodeficiencies.
Fischer A; Hacein-Bey S; Le Deist F; De Saint Basile G; Cavazzana-Calvo M
Adv Exp Med Biol; 2001; 495():199-204. PubMed ID: 11774567
[No Abstract] [Full Text] [Related]
11. Successful gene therapy for severe combined immunodeficiency.
Rosen FS
N Engl J Med; 2002 Apr; 346(16):1241-3. PubMed ID: 11961154
[No Abstract] [Full Text] [Related]
12. Recipient T-cell immune reconstitution in X-linked SCID after haploidentical maternal bone marrow transplant.
de la Morena MT; Wayne AS; Day NK; Haag MM; Hinds-Frey KR; Nelson RP; Sutcliffe MJ; Good RA
Ann N Y Acad Sci; 1995 Dec; 770():376-7. PubMed ID: 8597380
[No Abstract] [Full Text] [Related]
13. Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy.
Otsu M; Anderson SM; Bodine DM; Puck JM; O'Shea JJ; Candotti F
Mol Ther; 2000 Feb; 1(2):145-53. PubMed ID: 10933924
[TBL] [Abstract][Full Text] [Related]
14. Partial immune reconstitution after bone marrow transplantation in a boy with recombination activating gene 1 defect.
Muñoz-Robles J; Del Rey MJ; Ruiz-Contreras J; Clemente J; Ramos JT; Paz-Artal E; Allende LM
Bone Marrow Transplant; 2004 Apr; 33(8):877-8. PubMed ID: 14990985
[No Abstract] [Full Text] [Related]
15. Gene therapy for immune disorders: good news tempered by bad news.
Puck JM; Malech HL
J Allergy Clin Immunol; 2006 Apr; 117(4):865-9. PubMed ID: 16630946
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy of severe combined immunodeficiencies.
Fischer A; Hacein-Bey S; Cavazzana-Calvo M
Nat Rev Immunol; 2002 Aug; 2(8):615-21. PubMed ID: 12154380
[TBL] [Abstract][Full Text] [Related]
17. Clinical research. Gene therapy a suspect in leukemia-like disease.
Marshall E
Science; 2002 Oct; 298(5591):34-5. PubMed ID: 12364755
[No Abstract] [Full Text] [Related]
18. Cost analysis of treatments for severe combined immunodeficiency patients caused by adenosine deaminase deficiency: comparison of gene therapy and bone marrow transplantation.
Imai H
Hokkaido Igaku Zasshi; 1998 Mar; 73(2):137-45. PubMed ID: 9612707
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic defects of B cell function in X-linked severe combined immunodeficiency.
White H; Thrasher A; Veys P; Kinnon C; Gaspar HB
Eur J Immunol; 2000 Mar; 30(3):732-7. PubMed ID: 10741387
[TBL] [Abstract][Full Text] [Related]
20. [Successful gene therapy of children with severe immunodeficiency. Research breakthrough hopefully for the treatment of other diseases, too].
Fasth A; Mellgren K; Karlsson S; Richter J
Lakartidningen; 2002 Jul; 99(28-29):3010-2. PubMed ID: 12170507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
